GALANTAMINE

GALANTAMINE was reported 1658 times

GALANTAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYROID ATROPHY 9 0.0957
1 SEDATION COMPLICATION 237 0.0928
2 HIPPUS 1 0.0769
3 NEUROPSYCHOLOGICAL TEST ABNORMAL 3 0.0698
4 CREATININE RENAL CLEARANCE DECREASED 236 0.0589
5 MULTIPLE DRUG THERAPY 43 0.0570
6 MEDICAL DEVICE SITE GRANULOMA 1 0.0556
7 CREATININE RENAL CLEARANCE INCREASED 33 0.0441
8 COPROLALIA 2 0.0351
9 AUTOIMMUNE NEUROPATHY 4 0.0310
10 RECTAL ADENOMA 2 0.0256
11 VISUOSPATIAL DEFICIT 2 0.0220
12 BLOOD CALCIUM DECREASED 235 0.0209
13 APHANTASIA 1 0.0189
14 ANTICHOLINERGIC SYNDROME 28 0.0176
15 CAROTID SINUS SYNDROME 1 0.0167
16 IMMOBILISATION PROLONGED 2 0.0164
17 ORTHOSTATIC HYPOTENSION 285 0.0164
18 BLOOD LEAD INCREASED 1 0.0152
19 BLOOD ALUMINIUM INCREASED 1 0.0112
20 PLEUROTHOTONUS 10 0.0111
21 RENAL FUNCTION TEST ABNORMAL 49 0.0105
22 CSF GLUCOSE INCREASED 1 0.0104
23 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 4 0.0104
24 SEDATION 268 0.0102
25 ELECTROCARDIOGRAM Q WAVES 1 0.0098
26 RHYTHM IDIOVENTRICULAR 3 0.0092
27 NEUROBORRELIOSIS 1 0.0076
28 LOSS OF DREAMING 1 0.0075
29 HELICOBACTER PYLORI IDENTIFICATION TEST POSITIVE 1 0.0070
30 AORTIC ATHEROSCLEROSIS 1 0.0068
31 COGNITIVE DISORDER 312 0.0067
32 DEPRESSED LEVEL OF CONSCIOUSNESS 250 0.0063
33 CONFUSIONAL AROUSAL 1 0.0062
34 OESOPHAGEAL ACHALASIA 4 0.0062
35 ATHEROSCLEROSIS 2 0.0058
36 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
37 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 6 0.0056
38 DIAPHRAGMATIC RUPTURE 1 0.0056
39 VITAMIN K DEFICIENCY 2 0.0050
40 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 2 0.0050
41 AGNOSIA 1 0.0042
42 EXTRAVASATION BLOOD 1 0.0042
43 MYELOPROLIFERATIVE DISORDER 1 0.0041
44 VASCULITIC RASH 3 0.0039
45 COMPARTMENT SYNDROME 10 0.0038
46 ECZEMA INFECTED 1 0.0037
47 INCREASED BRONCHIAL SECRETION 9 0.0035
48 FLASHBACK 2 0.0035
49 BALANCE DISORDER 292 0.0034
50 HYPNAGOGIC HALLUCINATION 1 0.0033
51 ATYPICAL FRACTURE 2 0.0032
52 THYROXINE DECREASED 2 0.0032
53 MOBILITY DECREASED 232 0.0032
54 BLADDER DISORDER 32 0.0032
55 CHOLINERGIC SYNDROME 2 0.0031
56 POSTURE ABNORMAL 10 0.0031
57 ACQUIRED OESOPHAGEAL WEB 1 0.0029
58 SMALL FIBRE NEUROPATHY 2 0.0027
59 HEPATITIS TOXIC 7 0.0027
60 IMPAIRED REASONING 1 0.0026
61 ADMINISTRATION SITE REACTION 1 0.0026
62 ANTIPSYCHOTIC DRUG LEVEL INCREASED 7 0.0025
63 CARDIAC VENTRICULAR DISORDER 1 0.0024
64 PSYCHOTIC SYMPTOM 5 0.0024
65 DEMENTIA ALZHEIMER'S TYPE 4 0.0024
66 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
67 FRONTOTEMPORAL DEMENTIA 1 0.0023
68 AORTIC ARTERIOSCLEROSIS 6 0.0023
69 MENINGOENCEPHALITIS HERPETIC 1 0.0022
70 VITAMIN B12 DEFICIENCY 9 0.0022
71 CORONARY ANGIOPLASTY 1 0.0022
72 ESSENTIAL HYPERTENSION 4 0.0022
73 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
74 BODY MASS INDEX DECREASED 1 0.0022
75 EATING DISORDER SYMPTOM 1 0.0022
76 BLOOD CHOLESTEROL 1 0.0021
77 DEMENTIA 58 0.0021
78 APLASIA 4 0.0020
79 APRAXIA 3 0.0020
80 HYPOHIDROSIS 1 0.0020
81 LIBIDO INCREASED 4 0.0020
82 BREAST CONSERVING SURGERY 1 0.0020
83 STOMA SITE HAEMORRHAGE 3 0.0019
84 KELOID SCAR 1 0.0019
85 MALABSORPTION 10 0.0019
86 SINUS ARREST 3 0.0019
87 COGWHEEL RIGIDITY 2 0.0019
88 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
89 YAWNING 5 0.0019
90 GROIN INFECTION 1 0.0018
91 APNOEIC ATTACK 1 0.0018
92 BACTERIURIA 1 0.0018
93 HYPOAESTHESIA EYE 1 0.0017
94 ANTEROGRADE AMNESIA 1 0.0017
95 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
96 PARADOXICAL DRUG REACTION 6 0.0016
97 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
98 PERSECUTORY DELUSION 4 0.0016
99 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
100 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
101 NEUROPATHIC ARTHROPATHY 1 0.0015
102 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 12 0.0015
103 NASAL CRUSTING 1 0.0015
104 TOXICITY TO VARIOUS AGENTS 254 0.0015
105 HEAT ILLNESS 1 0.0015
106 ARTHROSCOPY 1 0.0015
107 HYPOTENSION 289 0.0014
108 PROCTALGIA 9 0.0014
109 MIOSIS 11 0.0014
110 HEMIANOPIA HOMONYMOUS 1 0.0014
111 CONSTIPATION 297 0.0014
112 CARCINOID TUMOUR 1 0.0013
113 HYPOSMIA 2 0.0013
114 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
115 CHOLANGITIS ACUTE 1 0.0013
116 PALLIATIVE CARE 2 0.0013
117 DROOLING 9 0.0013
118 GRIMACING 1 0.0013
119 BLOOD FIBRINOGEN INCREASED 1 0.0013
120 MYOCLONUS 15 0.0013
121 URINE FLOW DECREASED 3 0.0013
122 MEDICAL DEVICE SITE DISCOMFORT 1 0.0012
123 LYMPHANGITIS 1 0.0012
124 BREATH ODOUR 3 0.0012
125 KETONURIA 1 0.0012
126 COLONIC POLYP 2 0.0012
127 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
128 MYOCARDIAL FIBROSIS 1 0.0012
129 SLEEP TALKING 2 0.0012
130 DEVICE LOOSENING 1 0.0012
131 FALL 384 0.0012
132 DEVICE ALARM ISSUE 2 0.0011
133 GASTRIC PERFORATION 3 0.0011
134 NONSPECIFIC REACTION 6 0.0011
135 ON AND OFF PHENOMENON 6 0.0011
136 FREEZING PHENOMENON 4 0.0011
137 C-REACTIVE PROTEIN 1 0.0011
138 CARDIAC DYSFUNCTION 4 0.0011
139 BONE GRAFT 1 0.0011
140 FACIAL ASYMMETRY 1 0.0010
141 HYPERTONIC BLADDER 3 0.0010
142 BLADDER CATHETERISATION 1 0.0010
143 CONVERSION DISORDER 2 0.0010
144 HALLUCINATION 77 0.0010
145 DROWNING 1 0.0010
146 DEMYELINATING POLYNEUROPATHY 1 0.0010
147 DEVICE CONNECTION ISSUE 2 0.0009
148 SUDDEN DEATH 10 0.0009
149 BUNDLE BRANCH BLOCK LEFT 4 0.0009
150 GALLBLADDER ENLARGEMENT 1 0.0009
151 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
152 GASTRIC ULCER HAEMORRHAGE 5 0.0009
153 SALIVARY HYPERSECRETION 9 0.0009
154 DEMENTIA WITH LEWY BODIES 1 0.0009
155 TEMPERATURE REGULATION DISORDER 2 0.0009
156 MOANING 1 0.0009
157 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
158 BLOODY DISCHARGE 1 0.0009
159 DISTRACTIBILITY 1 0.0009
160 FOLATE DEFICIENCY 1 0.0009
161 SINUS TACHYCARDIA 12 0.0008
162 DELUSION 13 0.0008
163 MUSCLE RIGIDITY 10 0.0008
164 SLOW SPEECH 2 0.0008
165 DRUG INTERACTION 130 0.0008
166 BLOOD UREA DECREASED 1 0.0008
167 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
168 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
169 COMMUNICATION DISORDER 3 0.0008
170 INFUSION SITE IRRITATION 1 0.0008
171 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
172 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
173 BEHAVIOUR DISORDER 4 0.0007
174 CLUSTER HEADACHE 1 0.0007
175 STOMA SITE DISCHARGE 2 0.0007
176 ECCHYMOSIS 5 0.0007
177 HEMIPLEGIA 6 0.0007
178 PNEUMONIA ASPIRATION 18 0.0007
179 CHRONIC FATIGUE SYNDROME 1 0.0007
180 SKIN TOXICITY 4 0.0007
181 CATAPLEXY 1 0.0007
182 OESOPHAGEAL STENOSIS 2 0.0007
183 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
184 JUDGEMENT IMPAIRED 1 0.0007
185 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
186 BRADYKINESIA 4 0.0007
187 WHEELCHAIR USER 3 0.0007
188 PROTHROMBIN TIME PROLONGED 4 0.0007
189 HEPATITIS 17 0.0007
190 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
191 HYPERTHERMIA 5 0.0007
192 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
193 NEURITIS 1 0.0006
194 INHIBITORY DRUG INTERACTION 1 0.0006
195 INAPPROPRIATE AFFECT 1 0.0006
196 APHASIA 19 0.0006
197 HALLUCINATION, VISUAL 13 0.0006
198 HEPATITIS ACUTE 4 0.0006
199 BRADYARRHYTHMIA 1 0.0006
200 LISTLESS 2 0.0006
201 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
202 MEDICAL PROCEDURE 1 0.0006
203 MITRAL VALVE PROLAPSE 1 0.0006
204 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
205 CEREBRAL HAEMATOMA 2 0.0006
206 HEMIPARESIS 10 0.0006
207 SUBARACHNOID HAEMORRHAGE 6 0.0006
208 AKATHISIA 8 0.0006
209 LAZINESS 1 0.0006
210 BLOOD AMYLASE INCREASED 1 0.0006
211 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
212 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
213 REGURGITATION 2 0.0006
214 MILIARIA 1 0.0006
215 DIFFICULTY IN WALKING 2 0.0006
216 PARANOIA 10 0.0006
217 AMYLOIDOSIS 1 0.0006
218 BLOOD CHLORIDE INCREASED 1 0.0006
219 PARTIAL SEIZURES 3 0.0006
220 EMOTIONAL POVERTY 1 0.0006
221 INFUSION SITE DISCHARGE 1 0.0006
222 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
223 LOGORRHOEA 2 0.0006
224 DYSTONIA 11 0.0006
225 HAEMORRHOIDS 11 0.0006
226 ILEAL STENOSIS 1 0.0006
227 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
228 DEVICE KINK 2 0.0005
229 HYPERSEXUALITY 1 0.0005
230 MANIA 9 0.0005
231 INJECTION SITE CELLULITIS 1 0.0005
232 ANGIOPATHY 3 0.0005
233 ACUTE PULMONARY OEDEMA 3 0.0005
234 IMPULSIVE BEHAVIOUR 2 0.0005
235 IMPATIENCE 1 0.0005
236 SQUAMOUS CELL CARCINOMA 5 0.0005
237 GUN SHOT WOUND 1 0.0005
238 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
239 HYPERCHOLESTEROLAEMIA 5 0.0005
240 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
241 PARKINSONISM 5 0.0005
242 CONCOMITANT DISEASE PROGRESSION 1 0.0005
243 HYPOGEUSIA 1 0.0005
244 GAIT INABILITY 17 0.0005
245 HOSPICE CARE 5 0.0005
246 CELL DEATH 1 0.0005
247 HYPERLIPIDAEMIA 6 0.0005
248 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
249 AGGRESSION 25 0.0005
250 HEPATITIS CHOLESTATIC 3 0.0005
251 DRUG ABUSE 41 0.0005
252 NIPPLE PAIN 1 0.0005
253 DEMYELINATION 2 0.0005
254 CHOLANGITIS SCLEROSING 1 0.0005
255 AKINESIA 1 0.0005
256 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
257 CONFUSIONAL STATE 78 0.0005
258 APATHY 7 0.0005
259 DILATATION VENTRICULAR 1 0.0005
260 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
261 FRACTURE 9 0.0005
262 CIRCULATORY COLLAPSE 8 0.0005
263 ANAEMIA MACROCYTIC 1 0.0005
264 TEARFULNESS 2 0.0005
265 SOMNAMBULISM 3 0.0005
266 DISORIENTATION 18 0.0005
267 CLOSTRIDIUM TEST POSITIVE 1 0.0005
268 FIBROMYALGIA 11 0.0005
269 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
270 DANDRUFF 1 0.0005
271 FAECES PALE 1 0.0004
272 LIVER FUNCTION TEST ABNORMAL 13 0.0004
273 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
274 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
275 METASTASES TO MENINGES 1 0.0004
276 AGITATION 32 0.0004
277 HYPOMAGNESAEMIA 6 0.0004
278 THINKING ABNORMAL 8 0.0004
279 HEPATIC ENCEPHALOPATHY 4 0.0004
280 UNRESPONSIVE TO STIMULI 11 0.0004
281 PULSE ABSENT 2 0.0004
282 MEDICATION RESIDUE PRESENT 2 0.0004
283 LONG QT SYNDROME 1 0.0004
284 PAIN 251 0.0004
285 PSYCHIATRIC SYMPTOM 3 0.0004
286 BODY TEMPERATURE DECREASED 4 0.0004
287 HIP FRACTURE 13 0.0004
288 ABNORMAL BEHAVIOUR 16 0.0004
289 ABDOMINAL TENDERNESS 2 0.0004
290 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
291 HYPERNATRAEMIA 2 0.0004
292 CATHETER SITE HAEMORRHAGE 1 0.0004
293 EYELID IRRITATION 1 0.0004
294 PEMPHIGOID 3 0.0004
295 LABYRINTHITIS 1 0.0004
296 EXCORIATION 1 0.0004
297 HOSTILITY 1 0.0004
298 MOTOR DYSFUNCTION 4 0.0004
299 CACHEXIA 2 0.0004
300 CEREBRAL ISCHAEMIA 2 0.0004
301 BLOOD CHLORIDE DECREASED 1 0.0004
302 PLATELET COUNT INCREASED 5 0.0004
303 TORSADE DE POINTES 3 0.0004
304 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
305 MUCOSAL INFLAMMATION 10 0.0004
306 EXFOLIATIVE RASH 1 0.0004
307 DYSPHAGIA 36 0.0004
308 NASAL DISORDER 1 0.0004
309 HEPATIC STEATOSIS 7 0.0004
310 HYPOTHYROIDISM 12 0.0004
311 NIGHTMARE 13 0.0004
312 HYPOKALAEMIA 17 0.0004
313 DECUBITUS ULCER 3 0.0004
314 MIGRAINE WITH AURA 1 0.0004
315 HYDROCEPHALUS 2 0.0004
316 EMBOLISM 3 0.0004
317 STEVENS-JOHNSON SYNDROME 8 0.0004
318 CHOKING 7 0.0004
319 MALNUTRITION 4 0.0004
320 ELECTRIC SHOCK SENSATION 1 0.0004
321 ENDOTRACHEAL INTUBATION 1 0.0004
322 SUBDURAL HAEMATOMA 5 0.0003
323 ANGINA PECTORIS 10 0.0003
324 HYPERSOMNIA 10 0.0003
325 DELIRIUM 12 0.0003
326 DYSPNOEA AT REST 1 0.0003
327 METABOLIC DISORDER 2 0.0003
328 PRODUCT LABEL CONFUSION 2 0.0003
329 OVERDOSE 74 0.0003
330 DYSSTASIA 10 0.0003
331 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
332 NEGATIVE THOUGHTS 1 0.0003
333 NECK INJURY 1 0.0003
334 RESPIRATORY RATE INCREASED 3 0.0003
335 ARRHYTHMIA 16 0.0003
336 CHOLELITHIASIS 11 0.0003
337 BLOOD CULTURE POSITIVE 1 0.0003
338 METABOLIC ENCEPHALOPATHY 1 0.0003
339 CEREBROVASCULAR DISORDER 1 0.0003
340 EMERGENCY CARE 1 0.0003
341 EMBOLISM VENOUS 1 0.0003
342 URINARY RETENTION 11 0.0003
343 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
344 DYSURIA 12 0.0003
345 UROSEPSIS 3 0.0003
346 FIBROSIS 1 0.0003
347 LARYNGEAL OEDEMA 2 0.0003
348 SPEECH DISORDER 17 0.0003
349 DIASTOLIC DYSFUNCTION 1 0.0003
350 PERSONALITY CHANGE 3 0.0003
351 FAECES DISCOLOURED 7 0.0003
352 INFUSION SITE EXTRAVASATION 2 0.0003
353 PRE-EXISTING CONDITION IMPROVED 2 0.0003
354 BLOOD BLISTER 1 0.0003
355 BLOOD CREATININE DECREASED 1 0.0003
356 INVESTIGATION 1 0.0003
357 HYPOCALCAEMIA 6 0.0003
358 BREAST CANCER RECURRENT 1 0.0003
359 SPUTUM DISCOLOURED 3 0.0003
360 BILE DUCT STONE 1 0.0003
361 CHOLESTASIS 6 0.0003
362 AFFECT LABILITY 3 0.0003
363 SINUS BRADYCARDIA 3 0.0003
364 AMNESIA 20 0.0003
365 CEREBRAL HAEMORRHAGE 11 0.0003
366 FACET JOINT SYNDROME 1 0.0003
367 PSYCHOTIC DISORDER 9 0.0003
368 BEDRIDDEN 4 0.0003
369 INFUSION SITE HAEMORRHAGE 1 0.0003
370 DYSGRAPHIA 2 0.0003
371 BRADYCARDIA 16 0.0003
372 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
373 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
374 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
375 DYSKINESIA 12 0.0003
376 NEOPLASM RECURRENCE 1 0.0003
377 HEPATIC CYST 1 0.0003
378 INFARCTION 2 0.0003
379 EYE MOVEMENT DISORDER 2 0.0003
380 CERVICAL VERTEBRAL FRACTURE 1 0.0003
381 AORTIC STENOSIS 1 0.0003
382 CAROTID ARTERY STENOSIS 1 0.0003
383 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
384 SYNCOPE 28 0.0003
385 VISUAL FIELD DEFECT 2 0.0003
386 TONGUE DISORDER 2 0.0003
387 HYPOKINESIA 4 0.0003
388 MONOCYTE COUNT INCREASED 1 0.0003
389 MOUTH HAEMORRHAGE 2 0.0003
390 GASTROINTESTINAL PAIN 3 0.0003
391 MEMORY IMPAIRMENT 37 0.0003
392 DUODENAL ULCER PERFORATION 2 0.0003
393 RESPIRATORY DISORDER 8 0.0003
394 GASTRIC INFECTION 1 0.0003
395 CONCUSSION 2 0.0003
396 PRODUCT USE IN UNAPPROVED INDICATION 64 0.0003
397 HYPOALBUMINAEMIA 2 0.0003
398 SWOLLEN TONGUE 8 0.0003
399 RECTAL HAEMORRHAGE 11 0.0003
400 LYMPHADENOPATHY 9 0.0003
401 DRUG SCREEN POSITIVE 2 0.0003
402 BLOOD ALBUMIN DECREASED 2 0.0003
403 MENTAL STATUS CHANGES 7 0.0003
404 TRICUSPID VALVE INCOMPETENCE 2 0.0003
405 CEREBRAL ATROPHY 1 0.0003
406 PRESCRIBED UNDERDOSE 5 0.0003
407 FOREIGN BODY 1 0.0002
408 RHINITIS 2 0.0002
409 RESTLESSNESS 9 0.0002
410 RESPIRATORY DEPRESSION 3 0.0002
411 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
412 TREMOR 40 0.0002
413 CONGESTIVE CARDIOMYOPATHY 1 0.0002
414 HAEMODIALYSIS 2 0.0002
415 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
416 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
417 HYPERPYREXIA 1 0.0002
418 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
419 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
420 FACIAL PARALYSIS 2 0.0002
421 VITAMIN D DECREASED 2 0.0002
422 ANOREXIA 3 0.0002
423 INJECTION SITE INDURATION 3 0.0002
424 HEPATIC LESION 1 0.0002
425 MONOPLEGIA 1 0.0002
426 CARDIAC ARREST 19 0.0002
427 MELANOCYTIC NAEVUS 1 0.0002
428 GASTRITIS 6 0.0002
429 HAEMORRHAGIC ANAEMIA 1 0.0002
430 BLOOD CREATINE INCREASED 1 0.0002
431 HEPATOTOXICITY 5 0.0002
432 WRONG DRUG ADMINISTERED 2 0.0002
433 FACIAL PAIN 2 0.0002
434 JAUNDICE 6 0.0002
435 DRUG EFFECT DELAYED 1 0.0002
436 CONDITION AGGRAVATED 67 0.0002
437 HIDRADENITIS 2 0.0002
438 OSTEOPOROSIS 9 0.0002
439 ISCHAEMIA 1 0.0002
440 DEHYDRATION 29 0.0002
441 SEIZURE 25 0.0002
442 INTERCEPTED MEDICATION ERROR 1 0.0002
443 COORDINATION ABNORMAL 3 0.0002
444 PANCYTOPENIA 12 0.0002
445 GAIT DISTURBANCE 41 0.0002
446 URINARY TRACT INFECTION 36 0.0002
447 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
448 PARALYSIS 3 0.0002
449 HYPOVOLAEMIC SHOCK 1 0.0002
450 LIMB OPERATION 1 0.0002
451 CONTUSION 20 0.0002
452 INJECTION SITE HAEMATOMA 3 0.0002
453 GUILLAIN-BARRE SYNDROME 1 0.0002
454 DIZZINESS POSTURAL 2 0.0002
455 UNDERDOSE 15 0.0002
456 FOOT OPERATION 1 0.0002
457 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
458 HAEMATOCRIT DECREASED 4 0.0002
459 INABILITY TO AFFORD MEDICATION 2 0.0002
460 ERYSIPELAS 1 0.0002
461 HYPOTHERMIA 2 0.0002
462 DRUG DISPENSING ERROR 3 0.0002
463 EPILEPSY 6 0.0002
464 HYPONATRAEMIA 11 0.0002
465 ENDOCARDITIS 1 0.0002
466 THYROID DISORDER 3 0.0002
467 EJECTION FRACTION DECREASED 3 0.0002
468 HAEMATOMA 5 0.0002
469 FAILURE TO THRIVE 1 0.0002
470 RHABDOMYOLYSIS 8 0.0002
471 POLLAKIURIA 8 0.0002
472 DRUG-INDUCED LIVER INJURY 6 0.0002
473 DERMATITIS 4 0.0002
474 HEAD INJURY 6 0.0002
475 HALLUCINATION, AUDITORY 3 0.0002
476 ANORECTAL DISCOMFORT 1 0.0002
477 HEREDITARY ANGIOEDEMA 2 0.0002
478 HIP SURGERY 1 0.0002
479 ERYTHEMA OF EYELID 1 0.0002
480 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
481 PULMONARY THROMBOSIS 2 0.0002
482 OESOPHAGITIS 2 0.0002
483 ASPIRATION 2 0.0002
484 ASTHENOPIA 1 0.0002
485 DRUG LEVEL INCREASED 3 0.0002
486 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
487 BLOOD UREA INCREASED 3 0.0002
488 PULMONARY OEDEMA 8 0.0002
489 STATUS EPILEPTICUS 2 0.0002
490 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
491 NEUTROPHILIA 1 0.0002
492 PRODUCT AVAILABILITY ISSUE 4 0.0002
493 SCAB 2 0.0002
494 NEUROLOGICAL SYMPTOM 1 0.0002
495 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
496 SOMNOLENCE 35 0.0002
497 GASTRIC HAEMORRHAGE 2 0.0002
498 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
499 HYPERVENTILATION 1 0.0002
500 LOSS OF CONSCIOUSNESS 22 0.0002
501 SPLENOMEGALY 2 0.0002
502 SPINAL PAIN 2 0.0002
503 DEPRESSED MOOD 9 0.0002
504 URINARY INCONTINENCE 5 0.0002
505 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
506 BACTERAEMIA 2 0.0002
507 CATARACT OPERATION 1 0.0002
508 CARDIAC PACEMAKER INSERTION 1 0.0002
509 BLOOD PRESSURE FLUCTUATION 4 0.0002
510 GANGRENE 1 0.0002
511 LEUKOCYTOSIS 3 0.0002
512 INGUINAL HERNIA 1 0.0002
513 ACCIDENTAL OVERDOSE 6 0.0002
514 CARDIOMEGALY 2 0.0002
515 CHOLANGITIS 1 0.0002
516 EXTRAPYRAMIDAL DISORDER 4 0.0002
517 NASAL DRYNESS 1 0.0002
518 DECREASED APPETITE 37 0.0002
519 BLEPHAROSPASM 1 0.0002
520 BRAIN OEDEMA 2 0.0002
521 MUSCLE ATROPHY 2 0.0002
522 GASTRIC ULCER 3 0.0002
523 HAEMATEMESIS 4 0.0002
524 DYSPNOEA 89 0.0002
525 SLEEP APNOEA SYNDROME 3 0.0002
526 INCREASED APPETITE 3 0.0002
527 LETHARGY 9 0.0002
528 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
529 INCOHERENT 1 0.0002
530 BREAST CANCER STAGE III 1 0.0002
531 ANGINA UNSTABLE 1 0.0002
532 ASPERGILLUS INFECTION 1 0.0002
533 PULMONARY CONGESTION 2 0.0002
534 SARS-COV-2 TEST POSITIVE 2 0.0002
535 ADVERSE REACTION 2 0.0002
536 CARDIAC FAILURE ACUTE 1 0.0001
537 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
538 BODY TEMPERATURE INCREASED 3 0.0001
539 BLOOD TESTOSTERONE DECREASED 1 0.0001
540 OFF LABEL USE 128 0.0001
541 PERIPHERAL COLDNESS 2 0.0001
542 LARGE INTESTINE POLYP 1 0.0001
543 MEDICATION ERROR 8 0.0001
544 HYPERTRANSAMINASAEMIA 1 0.0001
545 APHONIA 2 0.0001
546 RENAL FAILURE 19 0.0001
547 CARPAL TUNNEL SYNDROME 2 0.0001
548 PERIPHERAL SWELLING 22 0.0001
549 KNEE ARTHROPLASTY 3 0.0001
550 DEVICE OCCLUSION 2 0.0001
551 SUICIDAL IDEATION 13 0.0001
552 BLINDNESS UNILATERAL 2 0.0001
553 TARDIVE DYSKINESIA 4 0.0001
554 MUSCULAR WEAKNESS 16 0.0001
555 JOINT INJURY 3 0.0001
556 LEUKOPENIA 7 0.0001
557 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
558 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
559 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
560 HYPERTHYROIDISM 2 0.0001
561 MENTAL DISORDER 6 0.0001
562 PRODUCT PRESCRIBING ISSUE 3 0.0001
563 CRYING 5 0.0001
564 PANIC ATTACK 5 0.0001
565 MELAENA 3 0.0001
566 INFUSION RELATED REACTION 9 0.0001
567 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
568 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
569 CEREBRAL DISORDER 1 0.0001
570 FEELING DRUNK 1 0.0001
571 ORAL PAIN 3 0.0001
572 HAEMORRHAGE INTRACRANIAL 2 0.0001
573 GENERAL SYMPTOM 1 0.0001
574 CHROMATURIA 3 0.0001
575 HEART RATE IRREGULAR 3 0.0001
576 DYSPNOEA EXERTIONAL 5 0.0001
577 SUICIDE ATTEMPT 8 0.0001
578 ILL-DEFINED DISORDER 8 0.0001
579 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
580 INSURANCE ISSUE 2 0.0001
581 HIP ARTHROPLASTY 2 0.0001
582 BOWEL MOVEMENT IRREGULARITY 1 0.0001
583 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
584 LIPASE INCREASED 1 0.0001
585 ATRIOVENTRICULAR BLOCK 1 0.0001
586 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
587 WEIGHT DECREASED 36 0.0001
588 LUNG INFECTION 2 0.0001
589 APNOEA 1 0.0001
590 THERAPY PARTIAL RESPONDER 2 0.0001
591 NERVOUS SYSTEM DISORDER 4 0.0001
592 HAEMORRHAGIC STROKE 1 0.0001
593 GASTROINTESTINAL INFLAMMATION 1 0.0001
594 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
595 AFFECTIVE DISORDER 1 0.0001
596 CYANOSIS 2 0.0001
597 ULCER 2 0.0001
598 ATRIAL FLUTTER 1 0.0001
599 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
600 SENSORY DISTURBANCE 2 0.0001
601 BLOOD PRESSURE INCREASED 19 0.0001
602 FRUSTRATION TOLERANCE DECREASED 1 0.0001
603 MUSCLE DISORDER 1 0.0001
604 ATRIAL FIBRILLATION 12 0.0001
605 ASPHYXIA 1 0.0001
606 HICCUPS 1 0.0001
607 VENTRICULAR TACHYCARDIA 2 0.0001
608 MUSCLE INJURY 1 0.0001
609 DIZZINESS 60 0.0001
610 COAGULOPATHY 2 0.0001
611 EOSINOPHIL COUNT INCREASED 1 0.0001
612 LIVE BIRTH 1 0.0001
613 EYE PRURITUS 4 0.0001
614 ANGER 4 0.0001
615 CARDIOVASCULAR DISORDER 3 0.0001
616 ANURIA 1 0.0001
617 BLOOD MAGNESIUM DECREASED 1 0.0001
618 NEUROPATHY PERIPHERAL 11 0.0001
619 DEAFNESS 3 0.0001
620 NAIL DISORDER 1 0.0001
621 DEPRESSION 26 0.0001
622 BLOOD CALCIUM INCREASED 1 0.0001
623 HEAD DISCOMFORT 2 0.0001
624 ISCHAEMIC STROKE 2 0.0001
625 ASTHENIA 42 0.0001
626 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
627 DISTURBANCE IN ATTENTION 6 0.0001
628 ANAL INCONTINENCE 1 0.0001
629 DRY MOUTH 9 0.0001
630 SYNOVITIS 2 0.0001
631 THROAT TIGHTNESS 3 0.0001
632 INFECTION 16 0.0001
633 LIP DRY 1 0.0001
634 MOOD ALTERED 3 0.0001
635 RESTLESS LEGS SYNDROME 2 0.0001
636 C-REACTIVE PROTEIN INCREASED 4 0.0001
637 SKIN LESION 3 0.0001
638 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
639 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
640 JOINT SWELLING 13 0.0001
641 BLISTER 6 0.0001
642 OEDEMA PERIPHERAL 13 0.0001
643 LACERATION 1 0.0001
644 ARTERIOSCLEROSIS 1 0.0001
645 MUSCULOSKELETAL DISORDER 2 0.0001
646 PRODUCTIVE COUGH 5 0.0001
647 MULTIPLE SCLEROSIS 5 0.0001
648 HERPES ZOSTER 6 0.0001
649 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
650 PRODUCT SUBSTITUTION ISSUE 6 0.0001
651 BLOOD GLUCOSE DECREASED 5 0.0001
652 LOWER LIMB FRACTURE 2 0.0001
653 ATELECTASIS 1 0.0001
654 PRESCRIBED OVERDOSE 2 0.0001
655 AUTOIMMUNE DISORDER 1 0.0001
656 DYSPHONIA 6 0.0001
657 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
658 COELIAC DISEASE 1 0.0001
659 DISEASE PROGRESSION 12 0.0001
660 EMBEDDED DEVICE 1 0.0001
661 GASTROINTESTINAL DISORDER 9 0.0001
662 UPPER LIMB FRACTURE 2 0.0001
663 THROMBOSIS 8 0.0001
664 SEPSIS 11 0.0001
665 FEEDING DISORDER 2 0.0001
666 TASTE DISORDER 2 0.0001
667 FLUID RETENTION 5 0.0001
668 NEUTROPHIL COUNT INCREASED 1 0.0001
669 INSOMNIA 26 0.0001
670 HELICOBACTER INFECTION 1 0.0001
671 HYPERBILIRUBINAEMIA 1 0.0001
672 EYE DISCHARGE 1 0.0001
673 PULMONARY HYPERTENSION 2 0.0001
674 FOLLICULITIS 1 0.0001
675 BRONCHITIS 7 0.0001
676 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
677 EATING DISORDER 2 0.0001
678 BODY HEIGHT DECREASED 1 0.0001
679 HYPERHIDROSIS 12 0.0001
680 NIGHT SWEATS 3 0.0001
681 PRURITUS GENERALISED 2 0.0001
682 ABDOMINAL PAIN UPPER 19 0.0001
683 BACK INJURY 1 0.0001
684 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
685 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
686 IMPAIRED HEALING 3 0.0001
687 BLOOD GLUCOSE FLUCTUATION 1 0.0001
688 EYE DISORDER 3 0.0001
689 MALAISE 40 0.0001
690 STAPHYLOCOCCAL INFECTION 3 0.0001
691 ANAPHYLACTIC REACTION 5 0.0001
692 TACHYCARDIA 8 0.0001
693 NERVE INJURY 1 0.0001
694 RASH MACULO-PAPULAR 2 0.0001
695 SNEEZING 2 0.0001
696 THROAT IRRITATION 4 0.0001
697 THERAPY NON-RESPONDER 4 0.0001
698 EYE INFECTION 1 0.0001
699 CEREBROVASCULAR ACCIDENT 15 0.0001
700 MITRAL VALVE INCOMPETENCE 1 0.0001
701 HAEMOGLOBIN DECREASED 9 0.0001
702 GASTRIC DISORDER 3 0.0001
703 NEPHROLITHIASIS 4 0.0001
704 CARDIAC FAILURE CONGESTIVE 7 0.0001
705 NEOPLASM 1 0.0001
706 METASTASES TO LUNG 1 0.0001
707 CHEST PAIN 16 0.0001
708 HAEMORRHAGE 9 0.0001
709 EYELID OEDEMA 1 0.0001
710 HYPERKALAEMIA 3 0.0001
711 SLEEP DISORDER 6 0.0001
712 HYPERTENSION 18 0.0001
713 COVID-19 PNEUMONIA 1 0.0001
714 ACCIDENT 1 0.0001
715 MACULAR DEGENERATION 1 0.0001
716 RASH ERYTHEMATOUS 4 0.0001
717 DIARRHOEA 54 0.0001
718 PRURITUS 32 0.0001
719 IRRITABILITY 5 0.0001
720 DRUG INTOLERANCE 8 0.0001
721 LOCALISED INFECTION 2 0.0001
722 MENTAL IMPAIRMENT 2 0.0001
723 HYPOGLYCAEMIA 4 0.0001
724 BURSITIS 1 0.0001
725 PRESYNCOPE 2 0.0001
726 VERTIGO 5 0.0001
727 DRUG INEFFECTIVE 108 0.0001
728 LUNG DISORDER 4 0.0001
729 LIVER INJURY 2 0.0001
730 PAIN IN EXTREMITY 24 0.0001
731 ENCEPHALOPATHY 2 0.0001
732 ABNORMAL WEIGHT GAIN 1 0.0001
733 EPISTAXIS 6 0.0001
734 DRUG WITHDRAWAL SYNDROME 7 0.0001
735 DYSARTHRIA 3 0.0001
736 DERMATITIS ALLERGIC 1 0.0001
737 GASTRIC CANCER 2 0.0001
738 INTRAOCULAR PRESSURE INCREASED 1 0.0001
739 ADVERSE DRUG REACTION 7 0.0001
740 THERAPY CESSATION 4 0.0001
741 INFUSION SITE PAIN 1 0.0001
742 HIATUS HERNIA 1 0.0001
743 MUSCULOSKELETAL PAIN 4 0.0001
744 HAND DEFORMITY 1 0.0001
745 DEATH 65 0.0001
746 CARDIAC FAILURE 6 0.0001
747 MALIGNANT MELANOMA 1 0.0001
748 ARTHRALGIA 31 0.0001
749 FEAR 2 0.0001
750 PALLOR 2 0.0001
751 DRUG TOXICITY 1 0.0001
752 ANAEMIA 14 0.0001
753 IMPAIRED GASTRIC EMPTYING 1 0.0001
754 TREATMENT NONCOMPLIANCE 4 0.0001
755 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
756 RESPIRATORY ARREST 2 0.0001
757 RESPIRATORY DISTRESS 2 0.0001
758 TREATMENT FAILURE 6 0.0001
759 FEELING COLD 2 0.0001
760 CARDIO-RESPIRATORY ARREST 3 0.0001
761 NECK PAIN 4 0.0001
762 MASS 1 0.0001
763 ABDOMINAL DISCOMFORT 12 0.0001
764 THROMBOCYTOPENIA 8 0.0001
765 WITHDRAWAL SYNDROME 3 0.0001
766 PRODUCT DOSE OMISSION ISSUE 21 0.0001
767 OXYGEN SATURATION DECREASED 4 0.0001
768 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
769 LYMPHOPENIA 1 0.0001
770 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
771 MYALGIA 12 0.0001
772 VOMITING 33 0.0001
773 BRONCHOSPASM 1 0.0001
774 RED BLOOD CELL COUNT DECREASED 2 0.0001
775 CARDIOGENIC SHOCK 1 0.0001
776 HYPOACUSIS 3 0.0001
777 EYE IRRITATION 4 0.0001
778 FATIGUE 54 0.0001
779 MYELODYSPLASTIC SYNDROME 1 0.0001
780 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
781 FLUSHING 7 0.0001
782 GASTROENTERITIS 1 0.0001
783 PALPITATIONS 8 0.0001
784 PNEUMONIA 22 0.0001
785 LABORATORY TEST ABNORMAL 2 0.0001
786 CARDIOMYOPATHY 1 0.0001
787 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
788 COLON CANCER 1 0.0001
789 LACRIMATION INCREASED 2 0.0001
790 NEUTROPENIA 9 0.0001
791 BLOOD COUNT ABNORMAL 1 0.0001
792 PLATELET COUNT DECREASED 7 0.0001
793 VISION BLURRED 9 0.0001
794 HEADACHE 41 0.0001
795 TINNITUS 3 0.0001
796 DRUG ADMINISTRATION ERROR 2 0.0001
797 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
798 LIMB DISCOMFORT 2 0.0001
799 MUSCULOSKELETAL CHEST PAIN 1 0.0001
800 BASAL CELL CARCINOMA 1 0.0001
801 BRAIN FOG 1 0.0001
802 PYREXIA 22 0.0001
803 ANXIETY 18 0.0001
804 MIGRAINE 6 0.0001
805 CYSTITIS 2 0.0001
806 ABSCESS 1 0.0001
807 FEELING ABNORMAL 15 0.0001
808 MOVEMENT DISORDER 2 0.0001
809 RHINORRHOEA 4 0.0001
810 RHEUMATOID ARTHRITIS 7 0.0001
811 BLOOD POTASSIUM INCREASED 1 0.0001
812 BLOOD CREATININE INCREASED 4 0.0001
813 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
814 EXPIRED PRODUCT ADMINISTERED 2 0.0001
815 CYTOMEGALOVIRUS INFECTION 1 0.0001
816 DRY EYE 3 0.0001
817 SKIN DISORDER 2 0.0001
818 CHILLS 7 0.0001
819 CELLULITIS 3 0.0001
820 NAUSEA 47 0.0001
821 HAEMATURIA 2 0.0001
822 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
823 MUSCULOSKELETAL DISCOMFORT 1 0.0001
824 DEVICE DEFECTIVE 1 0.0001
825 MYOCARDIAL INFARCTION 10 0.0001
826 MUSCULOSKELETAL STIFFNESS 5 0.0001
827 COVID-19 10 0.0001
828 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
829 LYMPHOCYTE COUNT DECREASED 1 0.0001
830 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
831 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
832 THERAPY INTERRUPTED 4 0.0001
833 ABDOMINAL PAIN 13 0.0001
834 OEDEMA 3 0.0001
835 DRUG EFFECT INCOMPLETE 2 0.0001
836 HYPERGLYCAEMIA 2 0.0001
837 BONE DISORDER 1 0.0001
838 RESPIRATORY FAILURE 4 0.0001
839 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
840 ADVERSE EVENT 5 0.0001
841 BLOOD GLUCOSE ABNORMAL 1 0.0001
842 HYPERSENSITIVITY 10 0.0001
843 EYE SWELLING 2 0.0001
844 MIDDLE INSOMNIA 1 0.0001
845 HYPOAESTHESIA 8 0.0001
846 INTESTINAL OBSTRUCTION 2 0.0001
847 BLOOD SODIUM DECREASED 1 0.0001
848 FLATULENCE 3 0.0001
849 UNEVALUABLE EVENT 4 0.0001
850 FOOT FRACTURE 1 0.0001
851 BLOOD URINE PRESENT 1 0.0001
852 DIABETES MELLITUS 4 0.0001
853 CONVULSION 3 0.0001
854 ACUTE RESPIRATORY FAILURE 1 0.0001
855 GLAUCOMA 1 0.0001
856 PARAESTHESIA 8 0.0001
857 WHEEZING 3 0.0001
858 DISABILITY 1 0.0001
859 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
860 BLOOD PRESSURE ABNORMAL 1 0.0001
861 INJECTION SITE BRUISING 4 0.0001
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
863 FULL BLOOD COUNT DECREASED 1 0.0000
864 EXTRA DOSE ADMINISTERED 2 0.0000
865 PLEURAL EFFUSION 3 0.0000
866 PSORIATIC ARTHROPATHY 2 0.0000
867 BONE MARROW FAILURE 1 0.0000
868 DISCOMFORT 3 0.0000
869 NEUTROPHIL COUNT DECREASED 2 0.0000
870 MUSCLE SPASMS 9 0.0000
871 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
872 LUNG NEOPLASM MALIGNANT 2 0.0000
873 VISUAL IMPAIRMENT 6 0.0000
874 ROAD TRAFFIC ACCIDENT 2 0.0000
875 RENAL FAILURE ACUTE 2 0.0000
876 IRRITABLE BOWEL SYNDROME 1 0.0000
877 LIVER FUNCTION TEST INCREASED 1 0.0000
878 COUGH 13 0.0000
879 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
880 VAGINAL HAEMORRHAGE 2 0.0000
881 SWELLING FACE 3 0.0000
882 DEVICE DISLOCATION 2 0.0000
883 RASH 20 0.0000
884 ACUTE KIDNEY INJURY 7 0.0000
885 INTENTIONAL PRODUCT MISUSE 4 0.0000
886 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
887 FEBRILE NEUTROPENIA 3 0.0000
888 GLOSSODYNIA 1 0.0000
889 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
890 ASTHMA 5 0.0000
891 BACK PAIN 10 0.0000
892 BLOOD CHOLESTEROL INCREASED 2 0.0000
893 DISEASE RECURRENCE 2 0.0000
894 COMA 2 0.0000
895 DIABETIC KETOACIDOSIS 1 0.0000
896 NEURALGIA 1 0.0000
897 CEREBRAL INFARCTION 1 0.0000
898 ABASIA 1 0.0000
899 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
900 AGEUSIA 1 0.0000
901 HOT FLUSH 3 0.0000
902 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
903 ABDOMINAL PAIN LOWER 1 0.0000
904 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
905 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
906 DIPLOPIA 1 0.0000
907 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
908 APPLICATION SITE ERYTHEMA 1 0.0000
909 PANCREATITIS 2 0.0000
910 PRODUCT USE ISSUE 7 0.0000
911 BLOOD GLUCOSE INCREASED 7 0.0000
912 DRUG EFFECT DECREASED 2 0.0000
913 FREQUENT BOWEL MOVEMENTS 1 0.0000
914 RASH PRURITIC 2 0.0000
915 LIMB INJURY 1 0.0000
916 HAEMATOCHEZIA 2 0.0000
917 DIVERTICULITIS 1 0.0000
918 ARTHROPATHY 2 0.0000
919 URTICARIA 6 0.0000
920 WEIGHT INCREASED 8 0.0000
921 RENAL IMPAIRMENT 3 0.0000
922 EYE PAIN 2 0.0000
923 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
924 NEEDLE ISSUE 1 0.0000
925 BONE PAIN 2 0.0000
926 DEVICE ISSUE 3 0.0000
927 BLOOD POTASSIUM DECREASED 1 0.0000
928 CORONARY ARTERY DISEASE 1 0.0000
929 STOMATITIS 2 0.0000
930 HOSPITALISATION 5 0.0000
931 EMOTIONAL DISORDER 1 0.0000
932 FEMUR FRACTURE 1 0.0000
933 CARDIAC DISORDER 3 0.0000
934 SWELLING 3 0.0000
935 BONE DENSITY DECREASED 1 0.0000
936 PULMONARY EMBOLISM 3 0.0000
937 MOOD SWINGS 1 0.0000
938 METABOLIC ACIDOSIS 1 0.0000
939 INTENTIONAL OVERDOSE 2 0.0000
940 LACTIC ACIDOSIS 1 0.0000
941 DYSPEPSIA 3 0.0000
942 HEART RATE INCREASED 3 0.0000
943 DEVICE DIFFICULT TO USE 2 0.0000
944 BLOOD PRESSURE DECREASED 2 0.0000
945 FUNGAL INFECTION 1 0.0000
946 DRY SKIN 4 0.0000
947 CHEST DISCOMFORT 3 0.0000
948 ILLNESS 3 0.0000
949 DEVICE USE ERROR 1 0.0000
950 ABDOMINAL DISTENSION 3 0.0000
951 HEART RATE DECREASED 1 0.0000
952 INJURY 2 0.0000
953 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
954 NASOPHARYNGITIS 5 0.0000
955 DYSGEUSIA 2 0.0000
956 CHRONIC KIDNEY DISEASE 2 0.0000
957 INCORRECT DOSE ADMINISTERED 6 0.0000
958 ARTHRITIS 2 0.0000
959 DEVICE BREAKAGE 1 0.0000
960 BLINDNESS 1 0.0000
961 ERYTHEMA 5 0.0000
962 INFLUENZA LIKE ILLNESS 2 0.0000
963 DRUG DOSE OMISSION 4 0.0000
964 DEVICE LEAKAGE 1 0.0000
965 PSORIASIS 3 0.0000
966 LIVER DISORDER 1 0.0000
967 PRODUCT QUALITY ISSUE 3 0.0000
968 BREAST CANCER 2 0.0000
969 ALOPECIA 4 0.0000
970 SINUSITIS 2 0.0000
971 ECZEMA 1 0.0000
972 DERMATITIS ATOPIC 1 0.0000
973 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
974 INFLUENZA 2 0.0000
975 NASAL CONGESTION 1 0.0000
976 BLADDER CANCER 1 0.0000
977 CATARACT 1 0.0000
978 EMOTIONAL DISTRESS 2 0.0000
979 DEEP VEIN THROMBOSIS 1 0.0000
980 NEOPLASM MALIGNANT 1 0.0000
981 HEPATIC ENZYME INCREASED 1 0.0000
982 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
983 ACNE 1 0.0000
984 INJECTION SITE HAEMORRHAGE 1 0.0000
985 DRUG DEPENDENCE 2 0.0000
986 COMPLETED SUICIDE 1 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
988 NO ADVERSE EVENT 2 0.0000
989 INJECTION SITE PAIN 3 0.0000
990 MALIGNANT NEOPLASM PROGRESSION 1 0.0000